In patients with NAFLD, a significant positive association was detected between serum levels of CK-18 and serum Alanine aminotransferase (ALT), suggesting that CK-18 can be a convenient biomarker for making the diagnosis of NAFLD [84]. The gene discussed is GPT; the disease is metabolic dysfunction-associated steatotic liver disease.